HUE065348T2 - Egy mutált H-faktor-kötõ fehérjét tartalmazó vakcinakészítmények - Google Patents
Egy mutált H-faktor-kötõ fehérjét tartalmazó vakcinakészítményekInfo
- Publication number
- HUE065348T2 HUE065348T2 HUE18209661A HUE18209661A HUE065348T2 HU E065348 T2 HUE065348 T2 HU E065348T2 HU E18209661 A HUE18209661 A HU E18209661A HU E18209661 A HUE18209661 A HU E18209661A HU E065348 T2 HUE065348 T2 HU E065348T2
- Authority
- HU
- Hungary
- Prior art keywords
- binding protein
- vaccine compositions
- mutated factor
- mutated
- factor
- Prior art date
Links
- 101710186862 Factor H binding protein Proteins 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0819633.9A GB0819633D0 (en) | 2008-10-25 | 2008-10-25 | Composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE065348T2 true HUE065348T2 (hu) | 2024-05-28 |
Family
ID=40133849
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE18209661A HUE065348T2 (hu) | 2008-10-25 | 2009-10-26 | Egy mutált H-faktor-kötõ fehérjét tartalmazó vakcinakészítmények |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20120052092A1 (OSRAM) |
| EP (2) | EP3501534B1 (OSRAM) |
| JP (2) | JP5676458B2 (OSRAM) |
| KR (3) | KR20170000390A (OSRAM) |
| CN (2) | CN102245202A (OSRAM) |
| AU (1) | AU2009306114B2 (OSRAM) |
| BR (1) | BRPI0919926A2 (OSRAM) |
| CA (1) | CA2741619A1 (OSRAM) |
| CO (1) | CO6382140A2 (OSRAM) |
| DK (1) | DK3501534T5 (OSRAM) |
| ES (1) | ES2970878T3 (OSRAM) |
| FI (1) | FI3501534T3 (OSRAM) |
| GB (1) | GB0819633D0 (OSRAM) |
| HR (1) | HRP20240226T1 (OSRAM) |
| HU (1) | HUE065348T2 (OSRAM) |
| LT (1) | LT3501534T (OSRAM) |
| MX (1) | MX2011004322A (OSRAM) |
| NZ (2) | NZ592444A (OSRAM) |
| PL (1) | PL3501534T3 (OSRAM) |
| PT (1) | PT3501534T (OSRAM) |
| RU (1) | RU2559528C2 (OSRAM) |
| SI (1) | SI3501534T1 (OSRAM) |
| WO (1) | WO2010046715A1 (OSRAM) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1093517T3 (da) | 1998-05-01 | 2008-06-23 | Novartis Vaccines & Diagnostic | Neisseria-meningitidis-antigener og præparater |
| NZ515935A (en) | 1999-05-19 | 2004-01-30 | Chiron S | Combination Neisserial compositions and vaccines for the prevention of infections due to Neisseria bacteria such as meningococcal meningitis |
| EP2275553B1 (en) | 1999-10-29 | 2015-05-13 | Novartis Vaccines and Diagnostics S.r.l. | Neisserial antigenic peptides |
| JP4763210B2 (ja) | 2000-02-28 | 2011-08-31 | ノバルティス ヴァクシンズ アンド ダイアグノスティクス エスアールエル | ナイセリアのタンパク質の異種発現 |
| GB0118249D0 (en) | 2001-07-26 | 2001-09-19 | Chiron Spa | Histidine vaccines |
| GB0121591D0 (en) | 2001-09-06 | 2001-10-24 | Chiron Spa | Hybrid and tandem expression of neisserial proteins |
| MXPA05003863A (es) | 2002-10-11 | 2005-09-08 | Chiron Srl | Vacunas polipeptidicas para amplia proteccion contra lineas hipervirulentas de meningococos. |
| GB0227346D0 (en) | 2002-11-22 | 2002-12-31 | Chiron Spa | 741 |
| GB0408977D0 (en) | 2004-04-22 | 2004-05-26 | Chiron Srl | Immunising against meningococcal serogroup Y using proteins |
| GB0524066D0 (en) | 2005-11-25 | 2006-01-04 | Chiron Srl | 741 ii |
| NZ587382A (en) | 2008-02-21 | 2012-01-12 | Novartis Ag | Meningococcal fhbp polypeptides |
| EP2265640B1 (en) | 2008-03-10 | 2015-11-04 | Children's Hospital & Research Center at Oakland | Chimeric factor h binding proteins (fhbp) containing a heterologous b domain and methods of use |
| NZ595234A (en) | 2009-03-24 | 2013-12-20 | Novartis Ag | Adjuvanting meningococcal factor h binding protein |
| WO2010127172A2 (en) | 2009-04-30 | 2010-11-04 | Children's Hospital & Research Center At Oakland | Chimeric factor h binding proteins (fhbp) and methods of use |
| WO2011051893A1 (en) | 2009-10-27 | 2011-05-05 | Novartis Ag | Modified meningococcal fhbp polypeptides |
| WO2011110634A1 (en) * | 2010-03-10 | 2011-09-15 | Glaxosmithkline Biologicals S.A. | Vaccine composition |
| CN110845585A (zh) * | 2010-03-30 | 2020-02-28 | 奥克兰儿童医院及研究中心 | 改性的h因子结合蛋白（fhbp）及其使用方法 |
| EP2585106A1 (en) | 2010-06-25 | 2013-05-01 | Novartis AG | Combinations of meningococcal factor h binding proteins |
| EP2809785B1 (en) | 2012-02-02 | 2017-11-01 | GlaxoSmithKline Biologicals SA | Promoters for increased protein expression in meningococcus |
| WO2013186753A1 (en) | 2012-06-14 | 2013-12-19 | Novartis Ag | Vaccines for serogroup x meningococcus |
| CA2875391A1 (en) | 2012-07-27 | 2014-01-30 | Institut National De La Sante Et De La Recherche Medicale | Cd147 as receptor for pilus-mediated adhesion of meningococci to vascular endothelia |
| WO2014140562A1 (en) * | 2013-03-14 | 2014-09-18 | Isis Innovation Limited | Immunogenic composition to neisseria |
| EP3027206A4 (en) | 2013-08-02 | 2017-03-08 | Children's Hospital & Research Center Oakland | Non-naturally occurring factor h binding proteins (fhbp) and methods of use thereof |
| SI3110442T1 (sl) | 2014-02-28 | 2021-01-29 | Glaxosmithkline Biologicals S.A. | Modificirani meningokokni fHbp polipeptidi |
| EP3172224B1 (en) | 2014-07-23 | 2022-06-29 | Children's Hospital & Research Center at Oakland | Factor h binding protein variants and methods of use thereof |
| KR102709811B1 (ko) * | 2014-08-20 | 2024-09-24 | 스티흐팅 산퀸 불드포르지닝 | 인자 h 강화 항체 및 그의 용도 |
| GB201614687D0 (en) * | 2016-08-31 | 2016-10-12 | Univ Oxford Innovation Ltd | fHbp scaffold |
| EP3607967A1 (en) | 2018-08-09 | 2020-02-12 | GlaxoSmithKline Biologicals S.A. | Modified meningococcal fhbp polypeptides |
| WO2020124159A1 (en) | 2018-12-21 | 2020-06-25 | Griffith University | Compositions, methods and uses for eliciting an immune response |
| WO2021007365A1 (en) * | 2019-07-08 | 2021-01-14 | Crapaud Bio, Inc. | Methods of making and using lipooligosaccharide compositions and vaccines |
| BR112022000739A2 (pt) | 2019-07-17 | 2022-04-12 | Gemini Therapeutics Sub Inc | Anticorpos de potencialização de fator h e usos dos mesmos |
| MX2023009728A (es) | 2021-02-19 | 2023-08-30 | Sanofi Pasteur Inc | Vacuna recombinante meningococica b. |
| TW202423477A (zh) | 2022-08-03 | 2024-06-16 | 美商賽諾菲巴斯德公司 | 針對腦膜炎奈瑟氏菌b的含佐劑免疫原性組成物 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4786592A (en) * | 1986-06-18 | 1988-11-22 | Scripps Clinic And Research Foundation | Neisseria gonorrhoeae lectin useful as a vaccine and diagnostic marker and means for producing this lectin |
| US5476784A (en) * | 1993-04-06 | 1995-12-19 | Rice; Peter A. | Gonococcal anti-idiotypic antibodies and methods and compositions using them |
| GB0220194D0 (en) * | 2002-08-30 | 2002-10-09 | Chiron Spa | Improved vesicles |
| US20070253964A1 (en) * | 2003-04-16 | 2007-11-01 | Zlotnick Gary W | Novel Immunogenic Compositions for the Prevention and Treatment of Meningococcal Disease |
| EP1855715B1 (en) * | 2005-01-27 | 2013-03-13 | Children's Hospital & Research Center at Oakland | Gna1870-based vesicle vaccines for broad spectrum protection against diseases caused by neisseria meningitidis |
| GB0524066D0 (en) * | 2005-11-25 | 2006-01-04 | Chiron Srl | 741 ii |
| US8039007B2 (en) * | 2006-06-29 | 2011-10-18 | J. Craig Venter Institute, Inc. | Polypeptides from Neisseria meningitidis |
| EP3017828A1 (en) * | 2009-08-27 | 2016-05-11 | GlaxoSmithKline Biologicals SA | Hybrid polypeptides including meningococcal fhbp sequences |
| CN110845585A (zh) * | 2010-03-30 | 2020-02-28 | 奥克兰儿童医院及研究中心 | 改性的h因子结合蛋白（fhbp）及其使用方法 |
-
2008
- 2008-10-25 GB GBGB0819633.9A patent/GB0819633D0/en not_active Ceased
-
2009
- 2009-10-26 FI FIEP18209661.0T patent/FI3501534T3/fi active
- 2009-10-26 CN CN2009801480003A patent/CN102245202A/zh active Pending
- 2009-10-26 US US13/125,957 patent/US20120052092A1/en not_active Abandoned
- 2009-10-26 HU HUE18209661A patent/HUE065348T2/hu unknown
- 2009-10-26 CN CN201510119007.XA patent/CN105412920A/zh active Pending
- 2009-10-26 PL PL18209661.0T patent/PL3501534T3/pl unknown
- 2009-10-26 KR KR1020167035443A patent/KR20170000390A/ko not_active Ceased
- 2009-10-26 KR KR1020117011885A patent/KR20110092282A/ko not_active Ceased
- 2009-10-26 EP EP18209661.0A patent/EP3501534B1/en active Active
- 2009-10-26 SI SI200932190T patent/SI3501534T1/sl unknown
- 2009-10-26 NZ NZ592444A patent/NZ592444A/xx unknown
- 2009-10-26 ES ES18209661T patent/ES2970878T3/es active Active
- 2009-10-26 RU RU2011120706/10A patent/RU2559528C2/ru not_active IP Right Cessation
- 2009-10-26 WO PCT/GB2009/051439 patent/WO2010046715A1/en not_active Ceased
- 2009-10-26 BR BRPI0919926A patent/BRPI0919926A2/pt not_active Application Discontinuation
- 2009-10-26 AU AU2009306114A patent/AU2009306114B2/en not_active Ceased
- 2009-10-26 JP JP2011532725A patent/JP5676458B2/ja not_active Expired - Fee Related
- 2009-10-26 HR HRP20240226TT patent/HRP20240226T1/hr unknown
- 2009-10-26 NZ NZ601538A patent/NZ601538A/en not_active IP Right Cessation
- 2009-10-26 LT LTEP18209661.0T patent/LT3501534T/lt unknown
- 2009-10-26 CA CA2741619A patent/CA2741619A1/en not_active Abandoned
- 2009-10-26 DK DK18209661.0T patent/DK3501534T5/da active
- 2009-10-26 MX MX2011004322A patent/MX2011004322A/es active IP Right Grant
- 2009-10-26 PT PT182096610T patent/PT3501534T/pt unknown
- 2009-10-26 EP EP09753188.3A patent/EP2355845B1/en not_active Not-in-force
- 2009-10-26 KR KR1020197002691A patent/KR20190011836A/ko not_active Ceased
-
2011
- 2011-05-05 CO CO11055224A patent/CO6382140A2/es not_active Application Discontinuation
-
2014
- 2014-12-25 JP JP2014261910A patent/JP6076326B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE065348T2 (hu) | Egy mutált H-faktor-kötõ fehérjét tartalmazó vakcinakészítmények | |
| PL2411048T3 (pl) | Adjuwantowe meningokokowe białko wiążące czynnik h | |
| GB2461546B (en) | Antigen binding polypeptides | |
| ZA201104397B (en) | Myostatin binding proteins | |
| GB2449354B (en) | Binding protein | |
| IL219202A0 (en) | Il-1 binding proteins | |
| ZA201105177B (en) | Il-1 binding proteins | |
| SG10201402960SA (en) | IL-17 Binding Proteins | |
| ZA201004133B (en) | Antigen binding proteins | |
| IL219048A (en) | Peptide compounds derived from urcl10 | |
| IL209585A0 (en) | Angiopoietin derived peptides | |
| PL2249996T3 (pl) | Zszywacz | |
| AU326166S (en) | Stapler | |
| EP2252326A4 (en) | VACCINE COMPOSITIONS | |
| GB0816976D0 (en) | Protein | |
| GB0801122D0 (en) | Vaccine composition | |
| PL118319U1 (pl) | Zszywacz | |
| AU326017S (en) | Stapler | |
| GB0818627D0 (en) | Protein | |
| GB0804680D0 (en) | Binding polypeptides | |
| GB0714346D0 (en) | binding peptides | |
| GB0702363D0 (en) | Vaccine composition | |
| IL210002A0 (en) | Antigen binding polypeptides | |
| GB0802326D0 (en) | Vaccine Composition | |
| GB0817077D0 (en) | Proteins |